Abstract:Borderline personality disorder (BPD) was introduced in the DSM‐III in 1980. From the DSM‐III to the DSM‐5, no major changes have occurred in its defining criteria. The disorder is characterized by instability of self‐image, interpersonal relationships and affects. Further symptoms include impulsivity, intense anger, feelings of emptiness, strong abandonment fears, suicidal or self‐mutilation behavior, and transient stress‐related paranoid ideation or severe dissociative symptoms. There is evidence that BPD can be reliably diagnosed and differentiated from other mental disorders by semi‐structured interviews. The disorder is associated with considerable functional impairment, intensive treatment utilization, and high societal costs. The risk of self‐mutilation and suicide is high. In the general adult population, the lifetime prevalence of BPD has been reported to be from 0.7 to 2.7%, while its prevalence is about 12% in outpatient and 22% in inpatient psychiatric services. BPD is significantly associated with other mental disorders, including depressive disorders, substance use disorders, post‐traumatic stress disorder, attention‐deficit/hyperactivity disorder, bipolar disorder, bulimia nervosa, and other personality disorders. There is convincing evidence to suggest that the interaction between genetic factors and adverse childhood experiences plays a central role in the etiology of BPD. In spite of considerable research, the neurobiological underpinnings of the disorder remain to be clarified. Psychotherapy is the treatment of choice for BPD. Various approaches have been empirically supported in randomized controlled trials, including dialectical behavior therapy, mentalization‐based therapy, transference‐focused therapy, and schema therapy. No approach has proved to be superior to others. Compared to treatment as usual, psychotherapy has proved to be more efficacious, with effect sizes between 0.50 and 0.65 with regard to core BPD symptom severity. However, almost half of the patients do not respond sufficiently to psychotherapy, and further research in this area is warranted. It is not clear whether some patients may benefit more from one psychotherapeutic approach than from others. No evidence is available consistently showing that any psychoactive medication is efficacious for the core features of BPD. For discrete and severe comorbid anxiety or depressive symptoms or psychotic‐like features, pharmacotherapy may be useful. Early diagnosis and treatment of BPD can reduce individual suffering and societal costs. However, more high‐quality studies are required, in both adolescents and adults. This review provides a comprehensive update of the BPD diagnosis and clinical characterization, risk factors, neurobiology, cognition, and management. It also discusses the current controversies concerning the disorder, and highlights the areas in which further research is needed.

Mutualistic processes in the development of psychopathology: The special case of borderline personality disorder.

Alexithymia, Affective Lability, Impulsivity, and Childhood Adversity in Borderline Personality Disorder

Subtypes of Borderline Personality Features in Adolescence: Insights from Cross-Lagged Panel Network Analysis.

The role of borderline personality disorder traits in predicting longitudinal variability of major depressive symptoms among a sample of depressed adults

Personality pathology in youth: A comparison of the categorical and alternative model in relation to internalizing and externalizing pathology and age-adequate psychosocial functioning.

Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies

Antecedents and risk factors for borderline personality disorder: Etiopathogenic models based on a multi-level meta-analysis

Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors

Identifying moderating factors during the preschool period in the development of borderline personality disorder: a prospective longitudinal analysis

Borderline personality disorder diagnosis in a new key

Borderline personality disorder and the big five: molecular genetic analyses indicate shared genetic architecture with neuroticism and openness

Exploring the p‐Factor in Adolescence: A Bifactor Exploratory Structural Equation Modeling Approach and Its Association With Emerging Personality Pathology

On the interplay of borderline personality features, childhood trauma severity, attachment types, and social support

Comparing the new concept of impairment in personality functioning with borderline personality disorder: differential psychosocial and psychopathological correlates in a clinical adolescent sample

The Complexity of Borderline Personality Disorder: Network Analysis of Personality Factors and Defense Styles in the Context of Borderline Personality Organization

Network Analysis of Borderline Personality Features in Adolescence Using a Screening Tool in a Chinese Community Sample

Mother-child interactions in adolescents with borderline personality disorder traits and the impact of early life maltreatment

How childhood maltreatment alters perception and cognition - the predictive processing account of borderline personality disorder

The Cognitive, Ecological, and Developmental Origins of Self-Disturbance in Borderline Personality Disorder

Borderline personality disorder features: the role of self-discrepancies and self-complexity

Differential associations between childhood maltreatment types and borderline personality disorder from the perspective of emotion dysregulation